Key Summary

  • Stock Movement: MDLN jumped 1.93% to $33.83, within its day range of 32.815 – 34.09.
  • Leveraged ETF Surge: Assets in leveraged U.S. Equity ETFs doubled in two months, reaching $84 billion by the end of May.
  • Korea/Taiwan ETFS: Leveraged ETFs on South Korea and Taiwan surged to $43.1 billion from $17 billion in the same period.
  • AI-Driven Growth: Major tech companies are expected to spend over $700 billion this year on AI infrastructure.

Medline Inc. (Nasdaq: MDLN) has drawn its second U.S. FDA warning in two months due to quality lapses.

In another market, assets in leveraged U.S. equity ETFs have doubled in two months. By the end of May, these investments totalled $84 billion, up from $39 billion in April. Additionally, leveraged ETFs on South Korea and Taiwan surged to $43.1 billion from $17 billion in the same period.

The growing interest in AI is partly driving the surge in leveraged ETFs. Major tech companies, including Alphabet, Microsoft, Meta, and Amazon, are expected to pour over $700 billion this year into capital expenditures for AI infrastructure. Analysts estimate that AI spending will climb above $1 trillion in 2027.

However, some analysts caution that the pace of the rally may be difficult to sustain. As Adam Crisafulli, Vital Knowledge founder, notes, the current environment shares some similarities with the late 1990s tech boom. The markets will have to absorb a lot of Supply in the coming months, which will be a test. Crisafulli warns that the parabolic price action usually cannot last forever.

The rising prices of AI stocks, such as Dell, which has doubled in a handful of days, may indicate unsustainable territory. The rally comes at a time when major tech companies are ramping up spending on AI infrastructure. South Korea and Taiwan markets are particularly popular and have recently surged past several long-established Western countries.

 

This article is intended for informational purposes only and does not constitute Investment advice or a recommendation to buy, sell, or hold any security. All information is sourced from publicly available data. Investors should conduct their own Due Diligence and consult a qualified financial adviser before making any investment decisions.